[Seroprevalence of hepatitis C virus among the multiply transfused].
A study was conducted on 61 polytransfused patients, 24 patients submitted to long lasting parenteral treatments, 116 blood donors and 132 controls. Immuno-enzymatic tests were used for detection of antibodies against hepatitis C virus (HCV). They were found in 56 (91.8%) out of the 61 polytransfused patients, in 5 (4.3%) of the donors, in 5 (20.8%) of the patients with multiple treatments and in 5 (3.7%) controls. The VHB markers were detected at variable rates in all investigated groups. The high rate of seropositivity indicates that hepatitis C is becoming an important public health problem in Romania.
Antipa
C
C
Institut de Virologie Stefan S. Nicolau, Bucarest, Roumanie.
Popescu
A
A
Teleguţă
M
M
Ruţă
S
S
Cernescu
C
C
Târdei
G
G
Copelovici
Y
Y
Stoian
M
M
Tivgă
N
N
Hoinărescu
M
M
D000328:Adult; D015415:Biomarkers; D001782:Blood Donors; D002648:Child; D006509:Hepatitis B / Q000453:epidemiology; D006510:Hepatitis B Antibodies / Q000097:blood; D006511:Hepatitis B Antigens / Q000097:blood; D006526:Hepatitis C / Q000453:epidemiology* / Q000635:transmission; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D015994:Incidence; D011183:Postoperative Complications / Q000453:epidemiology / Q000821:virology; D012383:Romania / Q000453:epidemiology; D016036:Seroepidemiologic Studies; D013789:Thalassemia / Q000150:complications / Q000628:therapy; D065227:Transfusion Reaction
D015415:Biomarkers; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D018937:Hepatitis C Antibodies